Andrew J. Fromkin
CIK 1341896 · President & CEO · last filed 2026-05-29
Andrew J. Fromkin is a President & CEO who has filed 30 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for IMVT, was dated May 29, 2026. Across all open-market trades the lifetime net is −$8.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.42M
5
30
-$8.42M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMVT | Director | 131,400 | $33.62 | $4.42M | -$8.56M | 12 | 2026-05-29 |
| Immunovant, Inc. (IMVTW) Delisted | Director | 24,700 | — | — | $0 | 2 | 2020-05-18 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | Director | — | — | — | $0 | 3 | 2016-01-14 |
| Radius Health, Inc. (RDUS) Delisted | President & CEO | — | $30.00 | — | $0 | 1 | 2013-11-18 |
| CLINICAL DATA INC (CLDA) Delisted | CEO, President | 0 | — | — | $137.0K | 11 | 2011-04-14 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-29 | IMVT | Mixed | −25,350 | -$5.82M | EDGAR |
| 2026-04-09 | IMVT | Grant (A) | +13,880 | $0 | EDGAR |
| 2025-12-03 | IMVT | Sell (S) | −22,249 | -$517.2K | EDGAR |
| 2025-04-03 | IMVT | Grant (A) | +16,188 | $0 | EDGAR |
| 2025-03-11 | IMVT | Sell (S) | −8,000 | -$156.8K | EDGAR |
| 2024-04-04 | IMVT | Grant (A) | +11,255 | $0 | EDGAR |
| 2023-12-05 | IMVT | Sell (S) | −12,350 | -$490.7K | EDGAR |
| 2023-04-14 | IMVT | Grant (A) | +12,523 | $0 | EDGAR |
| 2022-08-19 | IMVT | Grant (A) | +21,059 | $0 | EDGAR |
| 2022-01-12 | IMVT | Grant (A) | +21,726 | $0 | EDGAR |